| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872400 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusions: Our findings suggest that the ERCC4 T2505C polymorphism may be associated with improved recovery from radiation treatment toxicity in patients with OPSCC. Further study with larger sample sizes and prospective measure of radiotherapy-induced toxicity is warranted.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David G. M.D., Adam S. M.D., Yuxin M.D., Ph.D., Kristina R. B.S., Qingyi M.D., Ph.D., Erich M. M.D., M.P.H.,